New Tech Archives

Healthcare Industry News Weekly Wrap-Up: December 8, 2023

// Biotech and Pharma Therapeutics EyePoint sees stock surge on AMD drug trial data December 4, 2023 / Eyepoint / Drug Trial Data / Mid-stage Study / Eye Disease EyePoint’s medicine, called vorolanib, matched the performance of Regeneron’s top-selling drug...

December 8, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 10, 2023

// Biotech and Pharma Therapeutics AstraZeneca Pays $185M to Add Oral GLP-1 Drug Candidate to Pipeline November 9, 2023 / AstraZeneca / GLP-1 / Metabolic Disorder The available metabolic disorder drugs targeting the GLP-1 receptor are all injectable products. The...

November 10, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 3, 2023

// Biotech and Pharma Therapeutics GSK outpaces Pfizer in RSV vaccine market November 1, 2023 / GSK / Pfizer / RSV / Vaccine Though RSV is responsible for thousands of deaths and hospitalizations each year among young children and seniors,...

November 3, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 27, 2023

// Biotech and Pharma Therapeutics Why the evolution of patient advocacy organizations means better data for your rare disease trial October 23, 2023 / Drug Development / Patients / Clinical Trials As a Therapeutic Strategy Lead for Rare Disease at Worldwide...

October 27, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 6, 2023

// Biotech and Pharma Therapeutics Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar October 4, 2023 / Boehringer Ingelheim / Humira / AbbVie / Biosimilars After debuting its branded Humira biosim Cyltezo in July, Boehringer has launched...

October 6, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 8, 2023

// Biotech and Pharma Therapeutics Roche’s Genentech bets on radiopharmaceuticals in partnership with PeptiDream September 20, 2023 / Roche / PeptiDream / Cancer / Bristol Myers Interest in radiopharmaceuticals has been taking off ever since Novartis won drug approval of...

September 8, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 1, 2023

// Biotech and Pharma Therapeutics BMS publishes ‘modest’ multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, 2023 / Bristol Myers Squibb / Multiple Myeloma / Clinical Trial Data Bristol Myers Squibb has reported full phase 1 data...

September 1, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 25, 2023

// Biotech and Pharma Therapeutics Pfizer drops sickle cell disease collab with Syros inherited from GBT takeover July 24, 2023 / Pfizer / Syros Pharmaceuticals / Sickle Cell Disease / Beta Thalassemia At tail-end of 2019, GBT agreed to pay...

August 25, 2023